Valuation: Proto Script Pharmaceutical Corp.

Market Cap 1.97M 1.76M 1.62M 1.47M 2.75M 187M 2.8M 19.35M 7.71M 98.15M 7.38M 7.22M 310M P/E 2015 *
-
P/E 2016 -41.4x
Enterprise Value 2.01M 1.8M 1.66M 1.5M 2.81M 192M 2.87M 19.82M 7.9M 101M 7.56M 7.39M 317M EV / Sales 2015 *
-
EV / Sales 2016 394x
Free-Float
89.82%
Yield 2015 *
-
Yield 2016 -
1 day-50.00%
3 months-50.00%
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 1.0E-6
2.2
Manager TitleAgeSince
Chief Executive Officer 58 2016-06-28
Change 5-day change 1-year change 3-year change Capi.($)
-50.00%-.--%-66.67%-98.00% 5.69K
+2.48%+0.66%+18.35%+79.06% 745B
+2.47%-0.94%+14.84%+75.72% 84.5B
+2.05%+12.13%+36.89%+200.41% 72.73B
+0.71%-0.44%-22.01%+13.02% 46.97B
-5.68%+0.24%+41.17%+808.08% 49.98B
+2.31%-1.61%-4.03%+92.28% 45.47B
+1.71%+7.41%+22.25%+47.13% 33.97B
+0.53%-2.35%+39.35%+79.35% 25.99B
+1.30%+0.56%-61.58%-56.89% 25.45B
Average -4.67%+0.81%+1.86%+124.01% 113B
Weighted average by Cap. +0.79%-0.62%+16.51%+112.64%

Financials

2015 2016
Net sales 881K 788K 725K 658K 1.23M 83.92M 1.26M 8.68M 3.46M 44.01M 3.31M 3.24M 139M 789K 705K 649K 589K 1.1M 75.12M 1.12M 7.77M 3.09M 39.39M 2.96M 2.9M 124M
Net income -145K -130K -119K -108K -203K -13.83M -207K -1.43M -570K -7.25M -545K -533K -22.9M -7.18M -6.42M -5.91M -5.36M -10.04M -684M -10.23M -70.7M -28.17M -359M -26.95M -26.38M -1.13B
Net Debt 27.07K 24.19K 22.26K 20.22K 37.84K 2.58M 38.55K 266K 106K 1.35M 102K 99.42K 4.27M 47.78K 42.7K 39.3K 35.69K 66.8K 4.55M 68.06K 470K 187K 2.39M 179K 175K 7.53M
Logo Proto Script Pharmaceutical Corp.
Proto-Script Pharmaceuticals, Corp., formerly Yanex Group, Inc. is a development-stage company. The Company is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. The Company has various contracts with state and governmental insurance providers, among others. These contracts provide the Company the right to sell and repair DME. The Company's health care insurance contracts allow it the ability to service patients nationally. The Company intends to expand its market through additional contracts and open several repair facilities throughout the continental United States. The Company currently has repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California. As of June 30, 2016, the Company had not generated any revenues.
Employees
13
  1. Stock Market
  2. Stocks
  3. PSCR Stock